A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between ...

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...

Use of GLP-1 receptor agonists was associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes. Glucagon-like peptide-1 (GLP-1) receptor ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...

Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...

Among US adults without diabetes, the use of GLP-1 RAs increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022.

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Scientists have discovered how chemokines and G protein-coupled receptors selectively bind each other to control how cells move.

A landmark study in Current Neuropharmacology has uncovered a potential link between Glucagon-like Peptide-1 (GLP-1) receptor agonists—commonly found in popular drugs like Ozempic—and an ...

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...